These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36694492)

  • 1. A Case of Multiple Sclerosis Uncovered Following Moderna SARS-CoV-2 Vaccination.
    Ahoussougbemey Mele A; Ogbuagu H; Parag S; Pierce B
    Cureus; 2022 Dec; 14(12):e32799. PubMed ID: 36694492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.
    Quintanilla-Bordás C; Gascón-Gimenez F; Alcalá C; Payá M; Mallada J; Silla R; Carratalà-Boscà S; Gasque-Rubio R; Castillo J; Casanova B
    Front Neurol; 2022; 13():897275. PubMed ID: 35572939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review.
    Matsumoto Y; Ohyama A; Kubota T; Ikeda K; Kaneko K; Takai Y; Warita H; Takahashi T; Misu T; Aoki M
    Front Neurol; 2022; 13():845755. PubMed ID: 35299613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Disseminated Encephalomyelitis (ADEM) After Consecutive Exposures to Mycoplasma and COVID Vaccine: A Case Report.
    Mousa H; Patel TH; Meadows I; Ozdemir B
    Cureus; 2022 Jun; 14(6):e26258. PubMed ID: 35911280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case report.
    Gustavsen S; Nordling MM; Weglewski A
    Bull Natl Res Cent; 2023; 47(1):5. PubMed ID: 36643729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
    Nojszewska M; Kalinowska A; Adamczyk-Sowa M; Kułakowska A; Bartosik-Psujek H
    Neurol Neurochir Pol; 2021; 55(1):8-11. PubMed ID: 33555604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination.
    Czarnowska A; Kapica-Topczewska K; Tarasów E; Tarasiuk J; Chorąży M; Kochanowicz J; Kułakowska A
    Front Neurol; 2023; 14():1097799. PubMed ID: 36873437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab.
    Räuber S; Willison A; Korsen M; Kölsche T; Golombeck KS; Plaack B; Schüller J; Huntemann N; Rolfes L; Schroeter CB; Nelke C; Regner-Nelke L; Förster M; Ringelstein M; Barnett MH; Hartung HP; Aktas O; Albrecht P; Ruck T; Melzer N; Meuth SG; Kremer D
    Front Immunol; 2022; 13():1037214. PubMed ID: 36618356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden Death Associated With Possible Flare-Ups of Multiple Sclerosis After COVID-19 Vaccination and Infection: A Case Report and Literature Review.
    Jeon YH; Choi S; Park JH; Lee JK; Yeo NS; Lee S; Suh YL
    J Korean Med Sci; 2023 Mar; 38(10):e78. PubMed ID: 36918031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 mRNA vaccination leading to CNS inflammation: a case series.
    Khayat-Khoei M; Bhattacharyya S; Katz J; Harrison D; Tauhid S; Bruso P; Houtchens MK; Edwards KR; Bakshi R
    J Neurol; 2022 Mar; 269(3):1093-1106. PubMed ID: 34480607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
    Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
    BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient.
    Etemadifar M; Sigari AA; Sedaghat N; Salari M; Nouri H
    Hum Vaccin Immunother; 2021 Oct; 17(10):3481-3483. PubMed ID: 34015240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data.
    Kshirsagar M; Nasir M; Mukherjee S; Becker N; Dodhia R; Weeks WB; Ferres JL; Richardson B
    JMIR Public Health Surveill; 2022 Nov; 8(11):e38898. PubMed ID: 36265135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
    Zheng C; Kar I; Chen CK; Sau C; Woodson S; Serra A; Abboud H
    CNS Drugs; 2020 Sep; 34(9):879-896. PubMed ID: 32780300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.
    Iannetta M; Landi D; Cola G; Campogiani L; Malagnino V; Teti E; Coppola L; Di Lorenzo A; Fraboni D; Buccisano F; Grelli S; Mozzani M; Zingaropoli MA; Ciardi MR; Nisini R; Bernardini S; Andreoni M; Marfia GA; Sarmati L
    Front Immunol; 2021; 12():796482. PubMed ID: 35111162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Extensive Deep Vein Thrombosis After Heterogeneous Administration of Moderna mRNA Booster Vaccine: A Case Report.
    Alarmanazi F; Bangash BA; Lahoti L; Farabi B
    Cureus; 2022 Jun; 14(6):e25779. PubMed ID: 35812633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-severe acute respiratory syndrome coronavirus-2 antibody responses following Pfizer-BioNTech vaccination in a patient with multiple sclerosis treated with ocrelizumab: a case report.
    Mado H; Kubicka-Bączyk K; Adamczyk-Sowa M
    J Int Med Res; 2021 Sep; 49(9):3000605211044378. PubMed ID: 34528472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.